Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Trevor D McKee
Affiliation
University Health Network
ORCID
Career Start Year
2001
Papers
53
H Index
24
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36810255
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.
JCI Insight
2023
35242448
Deep Learning Accurately Quantifies Plasma Cell Percentages on CD138-Stained Bone Marrow Samples.
J Pathol Inform
2022
35508166
Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche.
Immunity
2022
35587994
Development and Validation of a Digital Analysis Method to Quantify CD3-immunostained T Lymphocytes in Whole Slide Images of Crohn's Disease Biopsies.
Appl Immunohistochem Mol Morphol
2022
36938084
Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors.
Kidney Int Rep
2022
35978831
Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas.
Front Oncol
2022
34312483
Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma.
Commun Biol
2021
33651938
Mass Spectrometry Imaging Reveals a Gradient of Cancer-like Metabolic States in the Vicinity of Cancer Not Seen in Morphometric Margins from Microscopy.
Anal Chem
2021
33762578
Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Cell Death Dis
2021
34425963
Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study.
Mayo Clin Proc
2021
34711609
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.
Cancer Res
2021
32360427
Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease.
Mol Metab
2020
31866087
Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma.
J Thorac Cardiovasc Surg
2020
32042347
Towards extracellular matrix normalization for improved treatment of solid tumors.
Theranostics
2020
32391125
Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Oncotarget
2020
30983024
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease.
Aliment Pharmacol Ther
2019
31867322
Quantitative Visualization of Hypoxia and Proliferation Gradients Within Histological Tissue Sections.
Front Bioeng Biotechnol
2019
30093633
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
Oncogene
2019
31371388
Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth.
J Cell Biol
2019
31310580
Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetes.
Am J Physiol Endocrinol Metab
2019
29676815
Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach.
APMIS
2018
30135316
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.
JCI Insight
2018
30004666
Radiation and Heat Improve the Delivery and Efficacy of Nanotherapeutics by Modulating Intratumoral Fluid Dynamics.
ACS Nano
2018
29476017
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.
Clin Cancer Res
2018
29500362
Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma.
Sci Rep
2018
29492210
Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.
Oncotarget
2018
29508889
The expression of CD markers in solid tumors: Significance in metastasis and prognostic value.
Histol Histopathol
2018
29734804
Nanoparticle Formulation Derived from Carboxymethyl Cellulose, Polyethylene Glycol, and Cabazitaxel for Chemotherapy Delivery to the Brain.
Bioconjug Chem
2018
29453322
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Mol Cancer Res
2018
29097943
Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.
Contrast Media Mol Imaging
2017
29152107
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Oncotarget
2017
27310112
Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma.
J Drug Target
2016
28193010
Variations in the Abundance of Lipid Biomarker Ions in Mass Spectrometry Images Correlate to Tissue Density.
Anal Chem
2016
27618721
Identification of RSK and TTK as Modulators of Blood Vessel Morphogenesis Using an Embryonic Stem Cell-Based Vascular Differentiation Assay.
Stem Cell Reports
2016
27959931
MATE2 Expression Is Associated with Cancer Cell Response to Metformin.
PLoS One
2016
27709819
Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution.
Angew Chem Int Ed Engl
2016
26659571
RANKL blockade prevents and treats aggressive osteosarcomas.
Sci Transl Med
2015
28447939
A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland.
Stem Cell Reports
2015
25389372
Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.
Sci Signal
2014
24141625
Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response.
Clin Cancer Res
2013
28855967
QUANTIFYING NANOPARTICLE TRANSPORT <i>IN VIVO</i> USING HYPERSPECTRAL IMAGING WITH A DORSAL SKINFOLD WINDOW CHAMBER.
J Innov Opt Health Sci
2012
20516072
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
J Biol Chem
2010
20697156
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice.
J Clin Invest
2010
19151720
In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts.
Nat Methods
2009
16510565
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector.
Cancer Res
2006
15994941
Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line.
Cancer Res
2005
16089171
Green fluorescent protein (GFP)-expressing tumor model derived from a spontaneous osteosarcoma in a vascular endothelial growth factor (VEGF)-GFP transgenic mouse.
Comp Med
2005
14716306
Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors.
Nat Med
2004
12754503
Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation.
Nat Med
2003
14654530
Irradiation reduces interstitial fluid transport and increases the collagen content in tumors.
Clin Cancer Res
2003
1 - 50 of 53
Column Actions
Search
Recommended Authors
Mara Gilardi
Institute of Medical Genetics and Pathology.
Career Start Year
2014
Number of shared co-authors
0
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year
2012
Number of shared co-authors
0
Fabrice Lucien
Mayo Clinic
Career Start Year
2010
Number of shared co-authors
2
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
0
Minhyung Kim
Roswell Park Comprehensive Cancer Center
Career Start Year
2010
Number of shared co-authors
1
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year
2009
Number of shared co-authors
3
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
1
James M Barnes
Center for Bioengineering and Tissue Regeneration
Career Start Year
2007
Number of shared co-authors
0
Ludwig Dubois
Maastricht University
Career Start Year
2004
Number of shared co-authors
4
Natasja G Lieuwes
Maastricht University
Career Start Year
2003
Number of shared co-authors
3
Ivy X Chen
Massachusetts General Hospital
Career Start Year
2002
Number of shared co-authors
1
Hon S Leong
University of Toronto
Career Start Year
2002
Number of shared co-authors
2
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year
2002
Number of shared co-authors
0
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year
2001
Number of shared co-authors
0
Chantal Pauli
University Hospital Zurich
Career Start Year
2001
Number of shared co-authors
0
Christopher D Willey
University of Alabama at Birmingham
Career Start Year
2000
Number of shared co-authors
0
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
1
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year
1997
Number of shared co-authors
0
Marc Vooijs
Maastricht University Medical Centre+
Career Start Year
1997
Number of shared co-authors
3
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year
1995
Number of shared co-authors
8
Alexander D Borowsky
University of California Davis Health
Career Start Year
1995
Number of shared co-authors
1
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
0
Jacqueline F Donoghue
University of Melbourne
Career Start Year
1995
Number of shared co-authors
0
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
2
Frank C Marini
Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine
Career Start Year
1990
Number of shared co-authors
0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year
1989
Number of shared co-authors
1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
5
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Rakesh K Jain
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
10
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers
10
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
7
Paul D Waterhouse
Princess Margaret Cancer Centre/University Health Network
Co-authored papers
4
Robert G Bristow
University of Toronto
Co-authored papers
4
Ravi N Vellanki
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Co-authored papers
3
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
2
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Co-authored papers
2
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Jenna Sykes
St. Michael's Hospital, University of Toronto
Co-authored papers
2
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
2
Otto Sanchez
Ontario Tech University
Co-authored papers
2
Vipul Jairath
Schulich school of Medicine, Western University.
Co-authored papers
2
Hui Fang
Beihua University
Co-authored papers
2
Gaetano Zafarana
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Alexander G Beristain
BC Children's Hospital Research Institute
Co-authored papers
2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Shaf Keshavjee
University Health Network, University Health Network and University of Toronto
Co-authored papers
2
Peter Libby
Co-authored papers
1
David R McCready
University of Toronto, University Health Network
Co-authored papers
1
Jing Xu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Jeremy A Squire
University of Sao Paulo
Co-authored papers
1
Peter P Liu
Co-authored papers
1
Alan Dal Pra
University of Miami Miller School of Medicine
Co-authored papers
1
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Co-authored papers
1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers
1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
1
Christopher Fladd
Hospital for Sick Children
Co-authored papers
1
1 - 30